Keryx Biopharma Stock Price (NASDAQ:KERX)

Add to My Stocks
$5.52 $0.07 (1.28%) KERX stock closing price Mar 23, 2017 (Closing)
Keryx Biopharma
23 MAR 2017
amigobulls logo
KERX hand_up
KERX vs S&P 500
Closing Price: Mar 23, 2017
$5.52 ( 1.28%)
S&P 500
2346 ( -0.11%)
52 Week Price Range
1 Year Return: 23.02%
Q4 Growth*
Profitable ?
net image
2016 Q4 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Keryx Biopharma Snapshot Video

11 5 2

KERX Stock Details

Prev Close* : $5.45
Market Cap:
Day Low: $5.41
52 Week Low: $4.03
Open: $5.49
Volume: 1534543
Day High: $5.67
52 Week High: $7.80

Latest Stock Market News

Latest Articles

Keryx Biopharma News - From Partners

KERX Stockcharts

View KERX PE ratio, PS ratio stocks charts and compare with peers.
KERX Chart
Note: Compare Keryx Biopharma stock price history with the index and industry peers.

Keryx Biopharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Keryx Biopharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

KERX Industry Peers

Company Price Change (%)
Neogenomics (NEO)7.580.07 (0.92%)
Wave Life Sciences (WVE)25.60.2 (0.78%)
Ardelyx (ARDX)13.350.75 (5.32%)
Akebia Therapeutics (AKBA)9.10.03 (0.33%)
Fibrogen (FGEN)25.050 (0%)
Affymax (AFFY)0.050 (0%)
Japan Tob Inc (JAPAY)16.890.13 (0.76%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ALBIREO PHARMA (ALBO)23.783.48 (17.14%)
Trevena (TRVN)3.590.26 (7.81%)
Fate Therapeutics (FATE)4.640.24 (5.45%)
Sangamo BioSciences (SGMO)4.20.2 (5%)
Cara Therapeutics (CARA)16.690.6 (3.73%)
Lion Biotech (LBIO)7.40.25 (3.5%)
Immunomedics (IMMU)6.630.21 (3.27%)
Top gainers from Medical-Biomed-Genetics industry
* As of Mar 23, 2017
CompanyPriceChange (%)
Ultragenyx Pharma (RARE)71.996.37 (8.13%)
Stemline Therapeutics (STML)8.50.45 (5.03%)
Puma Biotech (PBYI)40.11.45 (3.49%)
MannKind (MNKD)1.950.07 (3.47%)
Emergent Biosolutions (EBS)28.361.01 (3.44%)
Five Prime Therapeutics (FPRX)34.891.16 (3.22%)
Idera Pharma (IDRA)2.420.07 (2.81%)
Top losers from Medical-Biomed-Genetics industry
* As of Mar 23, 2017

Keryx Biopharmaceuticals Stock News - Partner Headlines

Keryx Biopharma Financial Statements

income statement20152014201320122011
Net Sales Or Revenues13.68M10.82M7M-5M
Net Income-123.14M-111.51M-46.73M-22.72M-28.12M
Total Operating Expense118.1M121.55M54.07M27.07M33.74M
view Keryx Biopharmaceuticals income statement
balance sheet20152014201320122011
Total Assets258.68M103.62M60.76M18.56M43.48M
Total Liabilities171.75M30.14M15.36M8.07M12.44M
Shareholders Equity86.93M73.48M45.4M10.49M31.04M
view Keryx Biopharmaceuticals balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-35.57M2.55M6.4M-1.6M3.4M
Net Cash From (Used By) Operating Activities-127.45M-81M-34.31M-24.76M-22.82M
Increase (Decrease) In Prop Plant And Equipment-2.77M-1.48M-0.34M-0.02M-0.05M
view Keryx Biopharmaceuticals cashflow statement

Keryx Biopharma Stock Message Board

Keryx Biopharma stock price ended the last trading day at 5.45. Keryx Biopharma market capitalization is 611.55M and it represents the total market value of KERX stock. Keryx Biopharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Keryx Biopharma stock price and Keryx Biopharma share price mean the same thing. 1931300 KERX shares were traded yesterday, and Keryx Biopharma stock chart shows that the KERX stock quote hit a day high of 5.73 and day low of 5.37. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. To check the historical stock price movement, all time high, and all time low of KERX, view Keryx Biopharma stock price history.